Coronavirus News

Hydroxychloroquine Sulphate Market: Global Industry Valuation 2020| In Depth Analysis, Solution, Industry Influence By 2028

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Hydroxychloroquine Sulphate market.

Trusted Business Insights presents an updated and Latest Study on Hydroxychloroquine Sulphate Market 2019-2026. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Hydroxychloroquine Sulphate market during the forecast period (2019-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Global Hydroxychloroquine Sulphate Market Research Report 2020 (Includes Business Impact of COVID-19)

India Partially Lifts Export Ban on Potential Coronavirus Treatment After Trump’s retaliation threat. India manufactures over 70% of the World’s Hydroxychloroquine Sulphate. 50% of the USA demand for Hydroxychloroquine is fulfilled by India.

Indian pharmaceutical companies are raising monthly production of anti-malarial drug Hydroxychloroquine (HCQ) four times to 40 metric tonnes (MT) by the end April and five to six times to over 70 metric tonnes (MT) by May 2020. The plan to step up production came after the Government of India indicated it will help countries in dire need of the drug to fight novel coronavirus. At peak capacity, companies would produce 350 million tablets of 200 mg dosage every month. India’s own requirement is unlikely to exceed 100 million tablets for which the government of India has already placed an order with Indian domestic manufacturers Zydus Cadila and Ipca Laboratories. Industry experts say 100 million tablets are good enough to treat 70 million people if required.

To continue producing at peak production capacity Indian Pharmaceuticals companies will need the intervention of the Indian government as the key active pharmaceutical ingredient (API) required to manufacture Hydroxychloroquine Sulphate is supplied by China. Production has resumed in China, but Indian Pharmaceutical companies are already staring at increased bulk prices, fluctuating freight rates, and reduced frequency of cargo flights. Indian Pharma companies are in talks with the government to airlift API to active pharmaceutical ingredient (API) from China

Meanwhile, share prices of Zydis Cadila rallied 13% while Ipca Laboratories attained a lifetime high on the close of trading at NSE (National Stock Exchange India)

With US FDA approving Anti-Malarial Drugs Chloroquine And Hydroxychloroquine For Emergency Coronavirus Treatment, Hydroxychloroquine and Azithromycin are touted to be the miracle cure.

Health Experts estimate according to one projection, between 160 million and 214 million people in the US could be infected over the course of the epidemic. That could last months or even over a year, with infections concentrated in shorter periods. Jayaprakash Muliyil is one of Indias foremost epidemiologists estimates roughly 55% of India’s population can be infected with the deadly coronavirus. To the uninitiated, India has a population of 1.3 billion.

600mg of hydroxychloroquine daily along with Azithromycin for 5 days showed encouraging results. Despite its small sample size, the survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.

With the USA stockpiling malaria medicine for treating COVID-19 patients, will other countries will also follow the lead and will India will able to fulfill the Global Hydroxychloroquine Sulphate demand?

Health Experts estimate according to one projection, between 160 million and 214 million people in the US could be infected over the course of the epidemic. That could last months or even over a year, with infections concentrated in shorter periods. Jayaprakash Muliyil is one of Indias foremost epidemiologists estimates roughly 55% of India’s population can be infected with the deadly coronavirus. To the uninitiated, India has a population of 1.3 billion.

600mg of hydroxychloroquine daily along with Azithromycin for 5 days showed encouraging results. Despite its small sample size, the survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin.

This report studies the global Hydroxychloroquine Sulphate market status and forecast, categorizes the global Hydroxychloroquine Sulphate market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major hydroxychloroquine sulphate manufacturers covered in this report

Customized separate regional or country-level for Hydroxychloroquine Sulphate reports is available for the following regions:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Central & South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • Turkey
  • Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into

  • 100mg Hydroxychloroquine Sulphate
  • 200mg Hydroxychloroquine Sulphate

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

  • Discoid Lupus Erythematosus
  • Systemic Lupus Erythematosus
  • Rheumatoid arthritis
  • COVID-19 / CORONA

 

Key Stakeholders

  • Hydroxychloroquine Sulphate Manufacturers
  • Hydroxychloroquine Sulphate Distributors/Traders/Wholesalers
  • Hydroxychloroquine Sulphate Subcomponent Manufacturers
  • Industry Association
  • Downstream Vendors

Available Customizations

  • Regional and country-level analysis of the Hydroxychloroquine Sulphate market, by end-use.
  • Detailed analysis and profiles of additional market players.

Quick Read Table of Contents of this Report @ Global Hydroxychloroquine Sulphate Market Research Report 2020 (Includes Business Impact of COVID-19)

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580